Member Info for the_shareminator

http://www.lse.co.uk/ShareNews.asp?shareprice=RBS&code=gcryda1i&headline=RPTGerman_banks_count_cost_of_global_shipping_crisis

Haha glad to hear you still hold, the JMB will come. We've been around long enough. The question is how safe do we feel going in heavy at 365?

Are your dividend figures up to date and do they take into account the last trading update? Sounds like you're a little more negative on this following the spate of selling. Personally I see this as yet another AIM gift providing DWHT hold around current levels we look super cheap. This company have beaten profit expectations set during the interims and yet DWHA are trading lower since then!. "The combined effects of these factors mean that the Board now anticipate full year profits will be significantly higher than current market expectations."

RRS analyst forecasts. Personally think the USD could push gold below $1300 short term so not looking to buy back here just yet. It already looks pricey but if the macro picture improves and the Dollar falls back this is worth a punt http://www.iii.co.uk/articles/351293/chart-week%3A-randgold-set-short-term-shine

Loving the new fame MBO is enjoying! This has blown my expectations out of the water :) Patience truly can pay off

Trading Update Dewhurst plc, an independent supplier of quality components to the lift, keypad and transport industries, is pleased to provide a trading update for the financial year ending 30 September 2016. The recovery reported at the interim stage has continued through the third quarter and into the fourth to date. Seasonal effects mean that the Company's second half is traditionally stronger than the first half, but the effect is expected to be greater than usual this year. The UK vote to leave the EU had an immediate effect on the value of the pound. A significant proportion of the Company's sales and earnings are generated in foreign currencies. With the fall in the pound these sales and earnings are worth more to us. If currencies remain broadly at today's level through to the end of September, it will benefit our reported sales and profits for the year, compared to expectations at the half year. The recent EU Referendum decision has not yet affected Dewhurst's underlying level of business. There have been reports in the media of cancellations and deferrals in commercial property transactions. However, whilst the decision has generated a period of uncertainty, it is too early to speculate what impact, if any, there will be on Dewhurst. The combined effects of these factors mean that the Board now anticipate full year profits will be significantly higher than current market expectations. jolly - with you on this one, we're nearly at the of the trading period and GBP is still weaker although it has strengthened recently. I would expect the strength of DWHT to spill over at some point between now and December when results are released. 800 - 500 by then?

Interim statement as expected below par.. "impacted by uncertainty in the UK market leading up to the EU referendum" Assuming that is not just an excuse, there should be a second half revival to look forward to now given the sector performance post Brexit. In for another bite

You might be right draft, no sellers about and the ASK is up to 4.4p Word is getting out and results for the first 6 months of this year are less than 4 weeks away now! :D

Looks overpriced and lacking a route to any meaningful growth. Author seems invested but doubt this is a safe play in the current climate https://masterinvestor.co.uk/equities/myhome-take-2-second-chance-franchise-brands/?utm_source=Master+Investor&utm_campaign=2254b5141f-Master_Investor_Daily_Bulletin8_22_2016&utm_medium=email&utm_term=0_25eff0bb7f-2254b5141f-34984745

Well it's been an exhilarating two month ride but I am out for now. This looks to be in overbought territory since bottoming. In any case, 30%+ overall gain in less than two months aint half bad :) gla

An impressive day on thin volume. It's difficult not to be excited by such movements but those following this will agree it's long overdue. The cash held in MYR has been appreciating in value when you convert to GBP and given last set of results we should be in for some collosal first half 2016 results. Not a ramp. Been here since 2p and my analysis and forecasts back then have been realised, often exceed by management. GLA

Banksman, when you consider how far PAF has risen there must be an awful lot of expectation built in already. My money is on this pulling back come results day unless precious metals continue to climb higher but good luck.

*Polish Zloty

Madrox is the fastest growing division and receives earnings in the Polish which has appreciated against Pound Sterling during the year. Demand at home will likely have fallen and the outlook downbeat. The dividend should continue though and possibly debt free in another 6 months

Gooch & Housego (GHH) is a world leader in the photonics technology market with manufacturing bases in the UK and US. The company covers the whole spread of activities from research to manufacturing components and systems for customers. The customer base covers, aerospace, defence, life sciences, industrial and scientific markets. Industrial still dominates revenues, but defence and life sciences are both growing strongly. Nearly three-fifths of revenues are generated in US dollars from North America and Asia Pacific. This year the company had a weak first quarter but stronger trading since then means that there will be profit growth this year. Gooch & Housego has one of the higher ratings among the companies in this article, but there are not many opportunities to acquire this type of business with its spread of activities and sectors. Recent add-on acquisitions have widened the group's capabilities and increased exposure to the defence sector. Net cash will still be £12 million at the end of September 2016 even after these purchases. The shares are trading on 22 times prospective earnings for the year to September 2016, falling to 20 next year. The shares are not a bargain on the basis of the short-term prospects, but this is a quality business that deserves a rating that reflects its strong market position.

INS is a consolidator in the life sciences IT market. The company provides software and services to help pharma companies to develop commercial drugs more efficiently and also to enable them to fulfil reporting and compliance regulations. Growth is coming from the implementation by the Food & Drug Administration (FDA) in the US of the Standard for Exchange of Non-clinical Data (SEND), which has to be adhered to by all drug developers. SEND became mandatory at the end of 2014 and Instem won the majority of the SEND business during 2015. Instem's strength in the SEND market would make it a good add-on for a rival. There is always plenty of regulation to provide opportunities for Instem. The European Medicines Agency (EMA) is implementing the standard developed by the ISO for the identification of medicinal products (IDMP). Companies will have to submit information and data on medicines and medical products in line with this format. At the end of May, Instem acquired regulatory information management services provider Samarind for up to £2.5m, which brings new customers to the group and is earnings enhancing. The software can be cross sold to SEND customers. This helps to offset the dilutive effect of raising £5 million from a placing earlier in the year in order to finance acquisitions. Instem pays dividends and has net cash that will continue to grow as cash is generated from operations. A pre-tax profit of £2.2 million is forecast for this year, rising to £2.8 million in 2017. The prospective 2017 multiple is 18.

Good to hear the word is spreading smudgedan, I've just been looking over Vox Markets, welcome a link here if you have it to hand :)

SEA7 - appreciate that but yesterdays update will have come as a surprise and despite alternate plans this is still likely to be a drawn out and costly process with no guarantee that RR will pay the outstanding sum if GDP win their case. If the switch-over is smooth and costs can be absorbed then nothing to worry about long term but I have seen these things drag on and become bigger than first appeared. It seems clear from the latest update Rand do not want business relations to continue as they will not be accept by-product materials for treatment in their smelter during the month of August, for "operational reasons". Does it not seem coincidental to investors here that just as GDP issue legal proceedings against RR, the latter party has declared no further by-product treatments at their smelter. Tit-for-tat perhaps and assume you are right about the bullion refining but this is certainly not healthy. At any rate it will be interesting to watch events unfold. Discodave - If you couldn't tell from my follow up posts I had simply misread who brought the action indeed in the first comment, which is why I corrected the post at 15:04 so no harm done. There is no means of editing posts once submitted so no need to take such a defensive stance with me. It certainly does not constitute libel, one random throwaway remark otherwise this site would have been closed down years ago. If you actually read what I wrote I didn't say anyone skimmed off the top, rather the accusation from your partner would be damaging. I had thought RR had brought the case against GDP and so the only cause for accusing GDP would be as I had suggested. As it so happens it's GDP who have accused RR of non-payment so no harm done. If you're worried about illegal practices though I am surprised you choose to invest money in the markets, especially AIM...

I think getting out today will prove a good call short term. I thought the breakout from the 1.08 range was a blessing at the time and not convinced we will see recent highs again any time soon.. Unless gold jumps above $1400 and continues to perform well

I had a scan through the last set of Interim and Full Year figures and posting my thoughts for my own interest so please ignore if you don't wish to read a negative review. I can't see any reason why operationally this will suddenly begin turning profits. Someone with a lot of cash, connected with the BOD can afford to pay a premium to the prevailing share price if they see future value in holding a large percentage of a company. There are many reasons for this including tax purposes. That doesn't mean this stock is worth the price paid. Falling net assets, cash burn and continual losses weigh heavy and lack of liquidity won't ease investor concerns when the next set of losses are announced. It's a far cry from what this company looked like back in 2011. Good luck to all holders but I'm keeping well clear